{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/acne-vulgaris/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"00cb6f19-98f0-5279-8ca3-56e9898a856b","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 66c6378f-2966-4ace-81e8-7e6eab43df49 --><h2>How should I assess a person with suspected acne vulgaris?</h2><!-- end field 66c6378f-2966-4ace-81e8-7e6eab43df49 -->","summary":"","htmlStringContent":"<!-- begin item 0cca3245-9427-42ae-a399-f0f7b2cf5a3b --><!-- begin field 6e4e2ec9-7826-452a-a12c-f9af7512a501 --><p><strong>Take a history asking about:</strong></p><ul><li>Duration, type and distribution of lesions.</li><li>Previous treatment (including over-the-counter medications) and response.</li><li>Exacerbating factors such as flares with menstruation, contraceptives, cosmetics, face creams or hair pomades.</li><li>Systemic features — some rare subtypes of acne (acne fulminans) can present with systemic features including fever, arthralgia, and myalgia.</li><li>Psychosocial impact of acne — ask about psychological problems including anxiety and low mood.</li><li>Family history including endocrine disorders, polycystic ovarian syndrome, acne and other skin conditions.</li><li>Possible underlying causes:<ul><li>Drug history — some medications can cause or exacerbate acneform rashes including androgens, corticosteroids, isoniazid, ciclosporin and lithium.</li><li>Hyperandrogenism — may present with irregular periods, androgenic alopecia or hirsutism in women.</li></ul></li></ul><p><strong>Examine the person:</strong></p><ul><li>Look for <a class=\"topic-reference internal-reference\" href=\"/topics/acne-vulgaris/diagnosis/clinical-features/\">clinical features</a> of acne such as non-inflammatory comedones and inflammatory papules, pustules, nodules and scarring.<ul><li>Comedones must be present for a diagnosis of acne to be made. If not present, consider <a class=\"topic-reference internal-reference\" href=\"/topics/acne-vulgaris/diagnosis/differential-diagnosis/\">alternative diagnoses</a>.</li><li>Record the type and distribution of lesions and severity.</li></ul></li><li>Look for signs of other disorders that can present with acne such as hyperandrogenism or Polycystic ovarian syndrome.<ul><li>For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/polycystic-ovary-syndrome/\">Polycystic ovary syndrome</a>.</li></ul></li></ul><h3>Investigations</h3><ul><li>Most people with acne do not require any investigations.</li><li>Consider appropriate investigations/referral to endocrinology for people presenting with clinical features of polycystic ovary syndrome (such as menstrual irregularity and hirsutism), or other endocrinopathy.</li></ul><!-- end field 6e4e2ec9-7826-452a-a12c-f9af7512a501 --><!-- end item 0cca3245-9427-42ae-a399-f0f7b2cf5a3b -->","topic":{"id":"4f10413c-64a7-5bb3-9003-1093b58e5700","topicId":"7737f6eb-1907-461e-a10b-166056e652b7","topicName":"Acne vulgaris","slug":"acne-vulgaris","lastRevised":"Last revised in August 2020","chapters":[{"id":"c13b5a16-bcf3-5b36-8dce-af226250264d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"318cce93-72af-5473-9c96-2577e69df14c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"6aac7922-c920-5394-bc2c-08ae3e93e4c5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b6ea59d7-e11c-59ba-ae3a-d12eda1c224b","slug":"changes","fullItemName":"Changes"},{"id":"501eff80-f5ab-5966-b79a-791cec9fcf7c","slug":"update","fullItemName":"Update"}]},{"id":"017f5393-8a9f-5cdb-9799-d9c32c6b50e9","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"32769738-e7d1-5c7a-a6ac-7e242b6ad659","slug":"goals","fullItemName":"Goals"},{"id":"60cde7a9-d789-5629-a7d6-e14882c6caf9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f91e328f-4d37-5a01-ab6d-edf7165acdaf","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"01961474-a4a0-5330-bc03-aca2c93fd7ed","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"867bb680-22ea-5d29-88b0-f219f9e8dae8","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8447443c-c6e1-5af4-ab33-68aa460c97b0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"10279ff1-6a1f-5af9-97b1-73405139911f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"13ced928-40f6-593c-8ae8-3d619c885e2e","slug":"definition","fullItemName":"Definition"},{"id":"290d67e9-4d5f-5a03-bafc-46380a14e964","slug":"causes","fullItemName":"Causes"},{"id":"2c90cfb7-ff4f-535b-b067-7b291de8de21","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5665dddd-4418-59f5-8480-8d73bc88b392","slug":"complications","fullItemName":"Complications"},{"id":"8e63da8e-8783-584a-962f-77fc8f5cda7c","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"cac20ff4-4d28-5a3d-ab66-5ad66ea6485d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"318b12a5-f38e-5aa0-866d-258e0bc4606b","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"00cb6f19-98f0-5279-8ca3-56e9898a856b","slug":"assessment","fullItemName":"Assessment"},{"id":"9a6b352b-2522-507b-baee-3746ed6c5fc1","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"93060cf3-048d-55d8-b979-1ee7c8b333d0","fullItemName":"Management","slug":"management","subChapters":[{"id":"8708236c-483d-548a-bcbb-ece4a63d3ef2","slug":"primary-care-management","fullItemName":"Scenario: Primary care management"}]},{"id":"ff879f6d-4cca-54e7-b137-1bea3673664f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"9c9958ec-2ef2-5cdd-8066-9039ba251071","slug":"benzoyl-peroxide","fullItemName":"Benzoyl peroxide"},{"id":"6d9ac0d3-8378-55b8-b6dc-17fb87472c20","slug":"topical-retinoids","fullItemName":"Topical retinoids"},{"id":"b3431b25-388f-5ae4-9ae3-fe13143c5d26","slug":"topical-antibiotics","fullItemName":"Topical antibiotics"},{"id":"9ca57669-ad06-5179-885d-5b8063e1323f","slug":"azelaic-acid","fullItemName":"Azelaic acid"},{"id":"8ae4cfcf-ffa5-5d2f-b469-369a52c50963","slug":"oral-antibiotics","fullItemName":"Oral antibiotics"},{"id":"dd897071-f76b-5e49-9c2d-e98f4b853afa","slug":"combined-oral-contraceptives","fullItemName":"Combined oral contraceptives"}]},{"id":"1a455bee-cdcd-5bfe-ac3c-92ebf7dc4f1b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c326d983-7898-5757-a2dd-0324dc5bca9a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7efc9e19-3f3c-5fe4-86af-6645e982294d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"5133582b-9a2b-5faf-a3be-a014b639deef","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"10179a08-abca-5ecd-982e-b1147cb710a3","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"25e71f93-96a6-5694-a7be-371938647a37","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"2adb6ee6-1991-50db-bb70-4a7b3d113064","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9f2f3c9d-3968-50fd-88cb-555214f14d6b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"cac20ff4-4d28-5a3d-ab66-5ad66ea6485d","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"a72f6026-c2b3-51dd-b6fb-cd9d542d241c","slug":"basis-for-recommendation-392","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field abc1acf3-8239-434e-b999-14b608fd4694 --><h3>Basis for recommendation</h3><!-- end field abc1acf3-8239-434e-b999-14b608fd4694 -->","summary":null,"htmlStringContent":"<!-- begin item 39278bdd-48a7-48ee-9f8a-486f8682ae3c --><!-- begin field d9cacc75-3095-4d77-aeb2-4f814d06614a --><p>The recommendations on the assessment of acne are based on clinical guidelines <em>Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Eichenfield, 2013</a>]. <em>Management of acne: Canadian clinical practice guideline</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Asai, 2016</a>], <em>A consensus-based practical and daily guide for the treatment of acne patients</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Gollnick, 2016</a>], <em>European evidence-based (S3) guideline for the treatment of acne – update 2016</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Nast, 2016</a>], <em>Guidelines of care for the management of acne vulgaris</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Zaenglein, 2016</a>], and <em>Acne: acne vulgaris</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">PCDS, 2018</a>], and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Bettoli, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Botros, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Moradi Tuchayi, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">BMJ Best Practice, 2017</a>].</p><h4>Ask about psychosocial impact</h4><ul><li>Acne is associated with significant psychological problems including an increased risk of depression, anxiety, reduced attachment to friends, low self-esteem and in some cases suicidal ideation. Identification of the extent of psychological impact is needed to direct management appropriately [<a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Dawson, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Moradi Tuchayi, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Asai, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Lynn, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Zaenglein, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Bienenfeld, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">de Vries, 2018</a>].</li></ul><h4>Grade severity</h4><ul><li>There is no universally agreed grading scale but it is generally accepted in the guidelines that categorising into mild, moderate and severe can be helpful in selection of appropriate treatment and monitoring of response [<a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Gollnick, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Nast, 2016</a>].</li></ul><h4>Investigations</h4><ul><li>Guidelines agree that generally no investigations are needed for the majority of people with acne. However, further investigation/referral to endocrinology is recommended for people presenting with acne and additional signs of androgen excess to identify an underlying cause [<a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Gollnick, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Nast, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">Zaenglein, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/acne-vulgaris/references/\">PCDS, 2018</a>].</li></ul><!-- end field d9cacc75-3095-4d77-aeb2-4f814d06614a --><!-- end item 39278bdd-48a7-48ee-9f8a-486f8682ae3c -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}